glp-1 препараты Агонисты рецепторов глюкагоноподобного пептида (ГПП) - список препаратов из 15.03 входит в группу клинико-фармакологических указателей (КФУ) 15 Пока страховщики борются с расходами

It is not widely prescribed

retail, international prescription referral services offer another path

In the UKPDS, sulfonylurea treatment caused a net weight gain of 3 kg, which occurred during the first 3-4 years of treatment and then stabilized [35]

She started with a wrinkle relaxer, convinced at first it would be a one-time thing

label momentum and cross-indication use with cardiomyopathy

With newer GLP-1based therapies now emerging, the field has an opportunity to test whether different drugs in this class have distinct effects on aging biology and to identify which patients may benefit most. Larger clinical trials will be needed to confirm these findings, determine how long the effects persist, and establish optimal dosing strategies and treatment durations for both people with HIV and the broader population